Original Cohort Clinical Study

Location: Essen, Germany and Nottingham, UK
Cohort: 19 male and 8 female patients aged 25 to 68, 8 primary snorers (AHI<5) and 19 mild OSA (AHI 5-15), Average BMI 29.7

82% of Bed Partners reported snoring reduction of an average of 40%

Overview

The original clinical trial with eXciteOSA® was a prospective multi-centre trial of individuals with snoring and/or mild OSA (AHI <15) led by Professor Boris Stuck.

Snoring was assessed using a bed partner reported visual analogue scale (VAS) (range 1-10, 10 = unbearable snoring). The snorers’ sleep quality was recorded using the Pittsburgh Sleep Quality Index (PSQI).

To minimise night-to-night variation in reported VAS, recordings over a 2-week period were averaged and compared: pre-treatment (2-weeks before the start of therapy), during treatment phase (last 2-weeks of 6-week therapy period) and post-treatment (2-weeks after stopping therapy).

The therapy was a 6-week daytime treatment period of intraoral tongue stimulation with the eXciteOSA® device for one 20-minute treatment a day.

Outcomes

The mean bed partner reporting snoring score reduced by 52% from 6.4 to 3.1 (p=0.001) with over 80% declaring a reduction of >40% in the reported snoring.

The change remained statistically significant for Primary Snorers (VAS reduction of 6.4 to 2.7, p=0.001) and Mild OSA patients (VAS reduction 6.6 to 3.6, p=0.001).

The VAS remained stable for the 2-weeks after stopping the therapy (mean VAS 3.3) suggesting a sustained change in muscle physiology.

There was also a statistically significant improvement in 3 of 8 components of the PSQI (Sleep Quality, Sleep Disturbance and GlobalScore), supporting a concurrent improvement in the snorer’s sleep quality with the use of the device.

Change in bed partner reported VAS in individual patients

{"type":"line","data":{"labels":[" RT "," ST "," IK "," JS "," RS "," DW "," CR "," BT "," CB "," MS "," HP "," SH "," SC "," MH "," DC "," TS "," GS "," MO "," MF "," LM "," GF "," MC "," KW "," TS "," KH "," KR "," PB "],"datasets":[{"label":"Before therapy","fill":false,"backgroundColor":"rgba(121,49,120,0.2)","lineTension":0.33299999999999996,"borderColor":"#793178","borderCapStyle":"butt","borderDash":[],"borderDashOffset":0,"borderJoinStyle":"miter","pointBorderColor":"#793178","pointBackgroundColor":"rgba(146,74,145,1)","pointHoverBackgroundColor":"#793178","pointHoverBorderColor":"rgba(146,74,145,1)","data":[8.7,7.6,9.4,8.1,8.3,8.2,5.4,5,8.2,5.4,2.5,8,8.9,6.9,2.6,4.5,4.6,5.7,5.7,8.3,6.1,6.7,5.7,8,4.6,7.5,2.7],"spanGaps":false,"showLine":false,"steppedLine":false,"pointStyle":"circle","hidden":false,"borderWidth":1,"pointRadius":3,"pointHitRadius":3,"pointBorderWidth":1,"pointHoverRadius":5,"pointHoverBorderWidth":1},{"label":"After therapy","fill":false,"backgroundColor":"rgba(53,171,226,0.2)","lineTension":0.33299999999999996,"borderColor":"#35abe2","borderCapStyle":"butt","borderDash":[],"borderDashOffset":0,"borderJoinStyle":"miter","pointBorderColor":"#35abe2","pointBackgroundColor":"rgba(47,153,203,1)","pointHoverBackgroundColor":"#35abe2","pointHoverBorderColor":"rgba(47,153,203,1)","data":[3.3,6.5,3.1,2.7,4.8,1.5,0.9,5.4,4.1,1.1,0.7,0.3,6.9,1.4,0.9,0.7,1,3.1,2.5,3.5,2.2,3.1,1.95,3.2,5.8,3.3,1.2],"spanGaps":false,"showLine":false,"steppedLine":false,"pointStyle":"circle","hidden":false,"borderWidth":1,"pointRadius":3,"pointHitRadius":3,"pointBorderWidth":1,"pointHoverRadius":5,"pointHoverBorderWidth":1}]},"options":{"animation":{"duration":2000},"maintainAspectRatio":true,"responsive":true,"aspectRatio":1.3333333333333333,"scales":{"yAxes":[{"ticks":{"fontColor":"rgba(100,100,100,0.8)","beginAtZero":true},"gridLines":{"color":"rgba(100,100,100,0.16)","zeroLineColor":"rgba(100,100,100,0.48)"},"stacked":false}],"xAxes":[{"ticks":{"fontColor":"rgba(100,100,100,0.8)"},"gridLines":{"color":"rgba(100,100,100,0.16)","zeroLineColor":"rgba(100,100,100,0.48)"}}]},"legend":{"display":true,"position":"bottom","labels":{"usePointStyle":false,"padding":20,"fontColor":"#3a3a3a"}},"tooltips":{"enabled":true,"mode":"index","intersect":false,"bodySpacing":8,"titleSpacing":6,"cornerRadius":8,"xPadding":10},"noTsep":false}}
["{y}","{y}"]

Change in mean VAS for Primary Snoring and Mild Sleep Apnea

{"type":"bar","data":{"labels":[" Primary Snorers "," Mild OSA Patients "],"datasets":[{"label":"PreTx","borderWidth":1,"borderColor":"rgba(121,49,120,0.9)","hoverBorderColor":"#793178","backgroundColor":"rgba(121,49,120,0.95)","hoverBackgroundColor":"#793178","data":[6.4,6.6],"hidden":false,"categoryPercentage":0.8,"barPercentage":0.9},{"label":"PostTx","borderWidth":1,"borderColor":"rgba(53,171,226,0.9)","hoverBorderColor":"#35abe2","backgroundColor":"rgba(53,171,226,0.95)","hoverBackgroundColor":"#35abe2","data":[2.7,3.6],"hidden":false,"categoryPercentage":0.8,"barPercentage":0.9}]},"options":{"animation":{"duration":2000},"maintainAspectRatio":true,"responsive":true,"aspectRatio":1.7777777777777777,"scales":{"yAxes":[{"ticks":{"fontColor":"rgba(100,100,100,0.8)","beginAtZero":true},"gridLines":{"color":"rgba(100,100,100,0.16)","zeroLineColor":"rgba(100,100,100,0.48)"}}],"xAxes":[{"ticks":{"fontColor":"rgba(100,100,100,0.8)"},"gridLines":{"color":"rgba(100,100,100,0.16)","zeroLineColor":"rgba(100,100,100,0.48)"}}]},"legend":{"display":true,"position":"bottom","labels":{"usePointStyle":false,"padding":20,"fontColor":"#3a3a3a"}},"tooltips":{"enabled":true,"mode":"index","bodySpacing":8,"titleSpacing":6,"cornerRadius":8,"xPadding":10},"noTsep":false}}
["PreTx: {y}","PostTx: {y}"]

Intraoral Electrical Muscle Stimulation in the Treatment of Snoring

Hear what other experts say about therapy with eXciteOSA®